Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...
Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.
An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Popular but pricey weight-loss drugs Ozempic and Wegovy are among the 15 medications whose prices will be subject to direct negotiations between Medicare and drug makers.
2d
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...
A look back at my 2024 predictions is revealing. . Each year I dust off my crystal ball and attempt to divine what lies ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback